Physician profile
James Bingham
NPI 1063413821
$1,536.95
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $183 · 2021: $327 · 2022: $227.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $337.49 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $229.07 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $172.54 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.09 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $90.94 | 2019-2022 | |
| Amarin Pharma, INC. | $73.30 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $70.08 | 2019-2021 | |
| Lilly USA, LLC | $67.26 | 2019-2022 | |
| Pfizer INC. | $58.76 | 2019-2020 | |
| Novo Nordisk INC | $56.23 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $55.66 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $42.95 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $37.54 | 2022 | |
| Abbvie INC. | $30.13 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $23.34 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.08 | 2019 | |
| Hikma Pharmaceuticals USA | $16.40 | 2019 | |
| Esperion Therapeutics, INC. | $15.28 | 2021 | |
| Dexcom, INC. | $12.91 | 2022 | |
| Sanofi Pasteur INC. | $11.71 | 2019 | |
| Shire North American Group INC | $11.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.